These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 26649645)

  • 1. Relationship between menopausal hormone therapy and mortality after breast cancer The MARIEplus study, a prospective case cohort.
    Obi N; Heinz J; Seibold P; Vrieling A; Rudolph A; Chang-Claude J; Berger J; Flesch-Janys D
    Int J Cancer; 2016 May; 138(9):2098-108. PubMed ID: 26649645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between menopausal hormone therapy, mammographic density and breast cancer risk: results from the E3N cohort study.
    Fornili M; Perduca V; Fournier A; Jérolon A; Boutron-Ruault MC; Maskarinec G; Severi G; Baglietto L
    Breast Cancer Res; 2021 Apr; 23(1):47. PubMed ID: 33865453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Menopausal hormone therapy use and breast cancer risk in Australia: Findings from the New South Wales Cancer, Lifestyle and Evaluation of Risk study.
    Salagame U; Banks E; Sitas F; Canfell K
    Int J Cancer; 2016 Apr; 138(8):1905-14. PubMed ID: 26599391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is breast cancer risk the same for all progestogens?
    Stute P
    Arch Gynecol Obstet; 2014 Aug; 290(2):207-9. PubMed ID: 24838289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Menopausal hormone therapy in relation to breast cancer characteristics and prognosis: a cohort study.
    Rosenberg LU; Granath F; Dickman PW; Einarsdóttir K; Wedrén S; Persson I; Hall P
    Breast Cancer Res; 2008; 10(5):R78. PubMed ID: 18803850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postmenopausal breast cancer risk and interactions between body mass index, menopausal hormone therapy use, and vitamin D supplementation: Evidence from the E3N cohort.
    Cadeau C; Fournier A; Mesrine S; Clavel-Chapelon F; Fagherazzi G; Boutron-Ruault MC
    Int J Cancer; 2016 Nov; 139(10):2193-200. PubMed ID: 27451078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic or Vaginal Hormone Therapy After Early Breast Cancer: A Danish Observational Cohort Study.
    Cold S; Cold F; Jensen MB; Cronin-Fenton D; Christiansen P; Ejlertsen B
    J Natl Cancer Inst; 2022 Oct; 114(10):1347-1354. PubMed ID: 35854422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediagnostic use of estrogen-only therapy is associated with improved colorectal cancer survival in menopausal women: a Swedish population-based cohort study.
    Simin J; Liu Q; Wang X; Fall K; Williams C; Callens S; Engstrand L; Brusselaers N
    Acta Oncol; 2021 Jul; 60(7):881-887. PubMed ID: 33861686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Menopausal hormone therapy and risk of breast cancer: a meta-analysis of epidemiological studies and randomized controlled trials.
    Greiser CM; Greiser EM; Dören M
    Hum Reprod Update; 2005; 11(6):561-73. PubMed ID: 16150812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of pre-diagnosis physical activity with recurrence and mortality among women with breast cancer.
    Schmidt ME; Chang-Claude J; Vrieling A; Seibold P; Heinz J; Obi N; Flesch-Janys D; Steindorf K
    Int J Cancer; 2013 Sep; 133(6):1431-40. PubMed ID: 23444048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association of breast cancer patients survival and prior menopausal hormone therapy in women with type 2 diabetes.
    Hosio M; Urpilainen E; Hautakoski A; Arffman M; Sund R; Ahtikoski A; Puistola U; Jukkola A; Läärä E; Karihtala P
    Sci Rep; 2024 Jul; 14(1):16478. PubMed ID: 39013999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Menopausal hormone therapy and breast cancer: what is the true size of the increased risk?
    Jones ME; Schoemaker MJ; Wright L; McFadden E; Griffin J; Thomas D; Hemming J; Wright K; Ashworth A; Swerdlow AJ
    Br J Cancer; 2016 Aug; 115(5):607-15. PubMed ID: 27467055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tamoxifen, hormone receptors and hormone replacement therapy in women previously treated for breast cancer: a cohort study.
    Dew JE; Wren BG; Eden JA
    Climacteric; 2002 Jun; 5(2):151-5. PubMed ID: 12051110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Female Estrogen-Related Factors and Incidence of Basal Cell Carcinoma in a Nationwide US Cohort.
    Cahoon EK; Kitahara CM; Ntowe E; Bowen EM; Doody MM; Alexander BH; Lee T; Little MP; Linet MS; Freedman DM
    J Clin Oncol; 2015 Dec; 33(34):4058-65. PubMed ID: 26527779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Menopausal hormone therapy use and long-term all-cause and cause-specific mortality in the Long Island Breast Cancer Study Project.
    Wang T; Bradshaw PT; Moorman PG; Nyante SJ; Nichols HB; Shantakumar S; Parada H; Khankari NK; Terry MB; Teitelbaum SL; Neugut AI; Gammon MD
    Int J Cancer; 2020 Dec; 147(12):3404-3415. PubMed ID: 32588422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations between diabetes medication use and risk of second breast cancer events and mortality.
    Calip GS; Yu O; Hoskins KF; Boudreau DM
    Cancer Causes Control; 2015 Aug; 26(8):1065-77. PubMed ID: 25956271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Menopausal hormone therapy and breast cancer risk: impact of different treatments. The European Prospective Investigation into Cancer and Nutrition.
    Bakken K; Fournier A; Lund E; Waaseth M; Dumeaux V; Clavel-Chapelon F; Fabre A; Hémon B; Rinaldi S; Chajes V; Slimani N; Allen NE; Reeves GK; Bingham S; Khaw KT; Olsen A; Tjønneland A; Rodriguez L; Sánchez MJ; Etxezarreta PA; Ardanaz E; Tormo MJ; Peeters PH; van Gils CH; Steffen A; Schulz M; Chang-Claude J; Kaaks R; Tumino R; Gallo V; Norat T; Riboli E; Panico S; Masala G; González CA; Berrino F
    Int J Cancer; 2011 Jan; 128(1):144-56. PubMed ID: 20232395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective effect of hormone therapy among women with hysterectomy/oophorectomy.
    Chen L; Mishra GD; Dobson AJ; Wilson LF; Jones MA
    Hum Reprod; 2017 Apr; 32(4):885-892. PubMed ID: 28184451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast cancer risk association with postmenopausal hormone therapy: Health Insurance Database in South Korea-based cohort study.
    Yuk JS; Kim T; Cho H; Gwak G
    Eur J Endocrinol; 2024 Jan; 190(1):1-11. PubMed ID: 38128117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T1N0 triple negative breast cancer: risk of recurrence and adjuvant chemotherapy.
    Kaplan HG; Malmgren JA; Atwood M
    Breast J; 2009; 15(5):454-60. PubMed ID: 19671105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.